I reported previously (July 2016) that Israel’s Micromedic Technologies had good results in an 18-patient trial of its CellDetect prostate cancer diagnosis solution. Latest tests on 59 samples were 80% successful – far exceeding the 25% for existing PSI tests.

https://www.israel21c.org/israeli-breakthrough-in-noninvasive-prostate-cancer-test/